Patent details

EP2767280 Title: ANEMIA OF CANCER IMPROVING / PROPHYLACTIC AGENT

The time of generation of the report may vary depending on the number of the selected files and the pages of each file. If the generation of the consolidated PDF file takes long, you may reduce the number of selected files and proceed with the generation of the PDF in batches.
You have not selected any documents

Unitary Effect

Unitary Effect Requested:
Yes
Unitary Effect Request Filing Date:
07/06/2024
Unitary Effect Status:
Unitary Effect Request Filed
Request Unitary Effect Accepted:
20/06/2024
Unitary Effect Date:
22/05/2024
Unitary Effect Registration Date:
20/06/2024
Request Unitary Effect Rejected:
Unitary Effect Re-establishment of rights Filing Date:
Unitary Effect Re-establishment of rights EPO Decision :
Unitary Effect Re-establishment of rights EPO Decision Date:
Unitary Effect Request Withdrawal Date:
Unitary Effect request has been filed
UPP register:
EP2767280
SPC Number:
Creation Date:

Basic Information

Publication number:
EP2767280
WO Application Number:
JP2012076020
Type:
European Patent Granted for NL
Status:
Unitary Effect Registered
Publication Title:
Title When Made Available For Viewing:
Reason Lapsed:
Application number:
EP12840143.7
WO Publication Number:
WO2013054770
EPO Publication Language:
English
SPC Number:
First Applicant Residence Country:
Japan (JP)
Publications:

Dates

Filing date:
05/10/2012
Grant date:
22/05/2024
EP Publication Date:
20/08/2014
WO Publication Date:
18/04/2013
Claims Translations Received Date:
Claims Translation B1 Received Date:
Claims Translation B2 Received Date:
Claims Translation B3 Received Date:
Lapsed By Non Payment Annual Fee Date:
Renunciation Date:
NullificationDate:
Published:
Due To Cession Date:
Registration date:
22/05/2024
EP B1 Publication Date:
22/05/2024
EP B2 Publication Date:
EP B3 Publication Date:
Description Translation B1 Received Date:
Description Translation B2 Received Date:
Description Translation B3 Received Date:
Expiration date:
04/10/2032
Lapsed By Expiration Date:
Revocation Date:
Invalidity Date:
Response To Novelty Search Report Received:
Patent Granting Request:
Lapsed date:

Applicant/holder

From:
22/05/2024
 
 

 

Name:
SBI Pharmaceuticals Co., Ltd.
Address:
6-1, Roppongi 1-chome Minato-ku, TOKYO 106-6020, Japan (JP)

Inventor

1

Name:
TANAKA, Tohru
Address:
Tokyo 106-6020, Japan (JP)

2

Name:
NAKAJIMA, Motowo
Address:
Tokyo 106-6020, Japan (JP)

3

Name:
ABE, Fuminori
Address:
Tokyo 106-6020, Japan (JP)

4

Name:
KAWATA, Satofumi
Address:
Tokyo 106-6020, Japan (JP)

5

Name:
TAKAHASHI, Kiwamu
Address:
Tokyo 106-6020, Japan (JP)

Priority

1

Priority Patent Number:
2012081346
Priority Date:
30/03/2012
Priority Country:
Japan (JP)

2

Priority Patent Number:
2011225383
Priority Date:
12/10/2011
Priority Country:
Japan (JP)

Classification

IPC or IDT classification:
A61K 31/197; A61K 31/28; A61K 33/06; A61K 33/24; A61K 33/26; A61K 33/30; A61K 33/34; A61P 7/06; A61P 43/00; A61K 31/295; A61P 35/00;

Publication

Bulletin

1

Bulletin Heading:
UP1
Journal edition number:
26/24
Publication date:
26/06/2024
Description:
European patents with registered Unitary Effect

2

Bulletin Heading:
EP2
Journal edition number:
21/24
Publication date:
22/05/2024
Description:
European patents granted for the Netherlands

European Patent Bulletin

1

Issue number:
202430
Publication date:
24/07/2024
Description:
Unitary Effect Request Acceptance

2

Issue number:
202429
Publication date:
17/07/2024
Description:
Unitary Effect Request Receipt

3

Issue number:
202421
Publication date:
22/05/2024
Description:
Grant (B1)

Annual Fee

Annual Fee(s) Due Date:
Annual Fee Number:
Last Annual Payment Date:
Last Annual Fee Paid Number:
Payer:
Filing date Document type Document Description Number of pages File Type